Media ReleasesInnate Immunotherapeutics

View All Innate Immunotherapeutics News


Innate Immunotherapeutics, Financial Statements for the Year Ended 31 March 2017

Contents

- Directors Report

- Auditor’s Independence Declaration

- Consolidated Statement of Profit or Loss and Other Comprehensive Income

- Consolidated Statement of Financial Position

- Consolidated Statement of Changes in Equity

- Consolidated Statement of Cash Flows

- Notes to the Financial Statements

- Directors’ Declaration

- Auditor’s Report


To view Report please download PDF attached: 
Download this document